HNF1A and maturity-onset diabetes of the young type 3: The understanding of the detailed molecular structure of the mutations in HNF1A that cause MODY3 is expected to serve as a platform for developing therapeutic approaches for patients with MODY3 and drug discovery for treating diabetes, and maycreate a path toward personalized medicine for diabetic patients.